转移性神经内分泌癌表现为多灶性肝病变伴甲胎蛋白升高。
Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha-fetoprotein.
作者信息
Sobotka Lindsay A, Hake Timothy, Kelly Crystal, Mousa Luay
机构信息
Department of Internal Medicine The Ohio State University Wexner Medical Center Columbus Ohio.
Department of Hematology The Ohio State Wexner Medical Center Columbus Ohio.
出版信息
Clin Case Rep. 2018 Dec 16;7(2):251-253. doi: 10.1002/ccr3.1956. eCollection 2019 Feb.
Abstract
Significant elevations in alpha-fetoprotein should raise suspicion for hepatocellular carcinoma as malignancies with metastasis to the liver can elevate the alpha-fetoprotein level but typically <300 ng/mL. Diagnosis should be confirmed with typical characteristics of hepatocellular carcinoma on imaging and or liver biopsy to confirm diagnosis.
摘要
甲胎蛋白显著升高应引起对肝细胞癌的怀疑，因为转移至肝脏的恶性肿瘤可使甲胎蛋白水平升高，但通常<300 ng/mL。诊断应通过影像学上肝细胞癌的典型特征和/或肝活检来确诊。
相似文献
1
Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha-fetoprotein.
Clin Case Rep. 2018 Dec 16;7(2):251-253. doi: 10.1002/ccr3.1956. eCollection 2019 Feb.
2
The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.
BMC Cancer. 2007 Feb 8;7:28. doi: 10.1186/1471-2407-7-28.
3
Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma.
Hepatology. 1991 Jul;14(1):68-72. doi: 10.1002/hep.1840140112.
4
Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C.
Dig Dis Sci. 1995 Dec;40(12):2587-94. doi: 10.1007/BF02220446.
5
False-negative rate of abdominal sonography for detecting hepatocellular carcinoma in patients with hepatitis B and elevated serum alpha-fetoprotein levels.
AJR Am J Roentgenol. 2004 Aug;183(2):453-8. doi: 10.2214/ajr.183.2.1830453.
6
Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma.
Hepatology. 1994 Dec;20(6):1418-25. doi: 10.1002/hep.1840200607.
7
Assessment of the Clinical Utility of Glypican 3 as a Serum Marker for the Diagnosis of Hepatocellular Carcinoma.
Technol Cancer Res Treat. 2016 Dec;15(6):780-786. doi: 10.1177/1533034615605248. Epub 2015 Sep 14.
8
Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions.
Gastroenterology. 1990 Aug;99(2):508-18. doi: 10.1016/0016-5085(90)91034-4.
9
Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.
Hepatology. 1994 Jan;19(1):61-6.
10
Serum alpha-fetoprotein levels and microheterogeneity in patients with different liver diseases.
J Hepatol. 1990 Sep;11(2):252-6. doi: 10.1016/0168-8278(90)90121-7.
引用本文的文献
1
Role of advanced imaging in primary hepatic neuroendocrine tumor with borderline raised AFP and negative chromogranin staining: A case report.
Int J Surg Case Rep. 2024 Dec;125:110647. doi: 10.1016/j.ijscr.2024.110647. Epub 2024 Nov 23.
2
Hepatocellular carcinoma with biliary and neuroendocrine differentiation: A case report.
World J Clin Oncol. 2021 Apr 24;12(4):262-271. doi: 10.5306/wjco.v12.i4.262.
本文引用的文献
1
When and how should we perform a biopsy for HCC in patients with liver cirrhosis in 2018? A review.
Dig Liver Dis. 2018 Jul;50(7):640-646. doi: 10.1016/j.dld.2018.03.014. Epub 2018 Mar 20.
2
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.
JAMA Oncol. 2017 Oct 1;3(10):1335-1342. doi: 10.1001/jamaoncol.2017.0589.
3
Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report.
World J Surg Oncol. 2016 Mar 15;14:84. doi: 10.1186/s12957-016-0838-0.
4
Pure alpha-fetoprotein-producing neuroendocrine carcinoma of the pancreas: a case report.
BMC Gastroenterol. 2015 Feb 12;15:16. doi: 10.1186/s12876-015-0246-x.
5
Testicular yolk sac tumors in children: a review of 61 patients over 19 years.
World J Surg Oncol. 2014 Dec 29;12:400. doi: 10.1186/1477-7819-12-400.
6
Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes.
Cancer. 2015 Feb 15;121(4):589-97. doi: 10.1002/cncr.29099. Epub 2014 Oct 13.
7
Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver.
BMC Gastroenterol. 2014 Jul 3;14:117. doi: 10.1186/1471-230X-14-117.
8
Tumor markers for hepatocellular carcinoma.
Mol Clin Oncol. 2013 Jul;1(4):593-598. doi: 10.3892/mco.2013.119. Epub 2013 May 13.
9
Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring.
Cancer Imaging. 2013 Feb 8;12(3):530-47. doi: 10.1102/1470-7330.2012.0044.
10
Alpha-fetoprotein and human chorionic gonadotrophin-beta as prognostic markers in neuroendocrine tumour patients.
Br J Cancer. 2008 Jul 8;99(1):72-7. doi: 10.1038/sj.bjc.6604428. Epub 2008 Jun 24.
Zotero 插件